Alvocade®

Bortezomib

Feel it in your bones

Product Information

  • Proprietary Name: Alvocade®
  • Generic Name: Bortezomib
  • Dosage Form: Vial
  • Strengths: 3.5 mg
  • Indications: Multiple Myeloma, Mantle Cell Lymphoma

Oncology

Alvocade®

Bortezomib is indicated for the treatment of multiple myeloma, and mantle cell lymphoma.

Ready to get started?

Curious about a specific position? Sign up for it.
© NanoAlvand. All rights reserved. Powered by ِDGN.